My Dashboard
Fin. Planning
Our Solutions
Stocks
Funds
Invest in the best stock opportunities right now and every time.
Start Systematic Stock Investing …in less than a minute.
BSE: 506260 | NSE: | Pharmaceuticals & Drugs | Small Cap
1. Is Anuh Pharma Ltd a good quality company?
Past 10 year's financial track record analysis by Moneyworks4me indicates that Anuh Pharma Ltd is a average quality company.
2. Is Anuh Pharma Ltd undervalued or overvalued?
The key valuation ratios of Anuh Pharma Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
3. Is Anuh Pharma Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Anuh Pharma Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘValue Creation Index Colour Code Guide ⓘ |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | |||
| ROCE % ⓘ | 20.1% | 24.7% | 24.6% | 25.3% | 15.2% | 10.7% | 16% | 10.3% | 12.1% | 15.1% | - | ||
| Value Creation Index ⓘ | 0.4 | 0.8 | 0.8 | 0.8 | 0.1 | -0.2 | 0.1 | -0.3 | -0.1 | 0.1 | - | ||
Growth Parameters ⓘGrowth Parameters Colour Code Guide ⓘ |
|||||||||||||
| Sales ⓘ | 243 | 266 | 284 | 326 | 206 | 238 | 321 | 307 | 432 | 487 | 492 | ||
| YoY Gr. Rt. % | - | 9.8% | 6.5% | 15% | -36.8% | 15.5% | 34.7% | -4.3% | 40.7% | 12.7% | - | ||
| Adj EPS ⓘ | 2.8 | 3.8 | 4.5 | 5.5 | 3.9 | 3.1 | 5 | 3.7 | 4.7 | 6.1 | 6.7 | ||
| YoY Gr. Rt. % | - | 36.4% | 16.8% | 22.9% | -29.4% | -20.7% | 64.2% | -27% | 26.9% | 31.3% | - | ||
| BVPS (₹) ⓘ | 15.1 | 17.1 | 20.1 | 23.8 | 28.1 | 29.9 | 32.9 | 32.4 | 38 | 42.7 | 44.3 | ||
| Adj Net Profit ⓘ | 14.1 | 19.2 | 22.3 | 27.5 | 19.4 | 15.4 | 25.3 | 18.5 | 23.4 | 30.7 | 34 | ||
| Cash Flow from Ops. ⓘ | 1.6 | 14.6 | 18.8 | 16.5 | 26.1 | 1.8 | 7.1 | 48.9 | -18.7 | 28.9 | - | ||
| Debt/CF from Ops. ⓘ | 0.3 | 0 | 0 | 0.1 | 0 | 1.3 | 0.6 | 0.9 | -0.7 | 0.1 | - | ||
CAGR ⓘCAGR Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9 Years | 5 Years | 3 Years | 1 Years | |||||||||
| Sales ⓘ | 8% | 18.7% | 14.9% | 12.7% | ||||||||
| Adj EPS ⓘ | 9.1% | 9.6% | 6.7% | 31.3% | ||||||||
| BVPS ⓘ | 12.2 | 8.8 | 9.1 | 12.2 | ||||||||
| Share Price | 13.8% | 0.5% | 12.2% | -13.2% | ||||||||
Key Financial Parameters ⓘPerformance Ratio Colour Code Guide ⓘ |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar'13 | Mar'14 | Mar'15 | Mar'16 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | TTM | ||
| Return on Equity % ⓘ | 19.4 | 23.7 | 23.9 | 25 | 14.9 | 10.6 | 16.1 | 11.3 | 13.3 | 15.2 | 15.4 | |
| Op. Profit Mgn % ⓘ | 8.3 | 10.5 | 11.9 | 12.3 | 11 | 8.6 | 10.8 | 10 | 10.5 | 10.1 | 10.3 | |
| Net Profit Mgn % ⓘ | 5.8 | 7.2 | 7.9 | 8.4 | 9.4 | 6.5 | 7.9 | 6 | 5.4 | 6.3 | 6.8 | |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0.1 | 0 | 0 | |
| Working Cap Days ⓘ | 111 | 127 | 127 | 116 | 176 | 153 | 139 | 169 | 153 | 162 | 194 | |
| Cash Conv. Cycle ⓘ | 29 | 26 | 29 | 33 | 58 | 62 | 54 | 47 | 32 | 50 | 105 | |
Return on Equity has increased versus last 3 years average to 15.40%
Sales growth is growing at healthy rate in last 3 years 14.92%
Sales growth is good in last 4 quarters at 17.93%
Net Profit has been subdued in last 3 years 6.74%
| Standalone | Consolidated | |
|---|---|---|
| TTM EPS (₹) | 6.7 | - |
| TTM Sales (₹ Cr.) | 492 | - |
| BVPS (₹.) ⓘ | 44.3 | - |
| Reserves (₹ Cr.) ⓘ | 197 | - |
| P/BV ⓘ | 2.11 | - |
| PE ⓘ | 13.92 | - |
| From the Market | |
|---|---|
| 52 Week Low / High (₹) | 82.50 / 129.45 |
| All Time Low / High (₹) | 0.03 / 218.70 |
| Market Cap (₹ Cr.) | 468 |
| Equity (₹ Cr.) | 25.1 |
| Face Value (₹) | 5 |
| Industry PE ⓘ | 37.5 |
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Anuh Pharma incorporated in 1960, is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.
The company has grown several immensely and earned recognition, besides gaining the trust of a strong customer base. Today, it is one of the largest producers of macrolides in the country.
Anuh Pharma has a product presence in Africa, Asia, Europe, Central/South America and the Middle East. The company's registered office is at E-17/3 and 17/4 MIDC, Tarapur, Boisar, Thane District 401506
Products
Recognitions/Certifications
